Biomarkers and genotypes in patients with Central nervous system infection caused by enterovirus.

PURPOSE

Enteroviruses (EV) comprises many different types and are the most common cause of aseptic meningitis. How the virus affects the brain including potential differences between types are largely unknown. Measuring biomarkers in CSF is a tool to estimate brain damage caused by CNS infections.

METHODS

A retrospective study was performed in samples from 38 patients with acute neurological manifestations and positive CSF-EV RNA ( = 37) or serum-IgM ( = 1). The EV in 17 samples were typed by sequencing. The biomarkers neurofilament light (NFL), glial fibrillary acidic protein (GFAP), S-100B protein, amyloid-β (Aβ) 40 and Aβ42, total-tau (T-tau) and phosphorylated tau (P-tau) were measured and compared with data derived from a control group ( = 19).

RESULTS

There were no increased levels of GFAP ( ≤ 0.1) nor NFL ( ≤ 0.1) in the CSF of patients with EV meningitis ( = 38) compared with controls. However, we found decreased levels of Aβ42 ( < 0.001), Aβ40 ( < 0.001), T-tau ( ≥ 0.01), P-tau ( ≤ 0.001) and S-100B ( ≤ 0.001). E30 ( = 9) and CVB5 ( = 6) were the most frequent EV-types identified, but no differences in biomarker levels or other clinical parameters were found between the infecting virus type. Seven patients who were followed for longer than one month reported remaining cognitive impairment, although no correlations with biomarker concentrations were observed.

CONCLUSION

There are no indication of neuronal or astrocyte damage in patients with EV meningitis. Yet, decreased concentrations of Aβ40, Aβ42, P-tau and T-tau were shown, a finding of unknown importance. Cognitive impairment after acute disease occurs, but with only a limited number of patients analysed, no conclusion can be drawn concerning any association with biomarker levels or EV types.